Azelis Group NV (HAM:2R7) Research & Development: €0 Mil (TTM As of Dec. 2025)


HAM:2R7 Azelis Group NV HAM:2R7
52 GF Score
Price €9.69
GF Value €18.35
Valuation Significantly Undervalued
! 4 Warning Signs
View Full Analysis

What is Azelis Group NV Research & Development?

Azelis Group NV HAM:2R7 -1.27% 52 Research & Development is €0 Mil as of Dec. 2025. GuruFocus rates HAM:2R7 with a GF Score™ of 52/100 and a GF Value™ of €18.35 (Significantly Undervalued). The stock has 4 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Azelis Group NV's Research & Development for the six months ended in Dec. 2025 was €0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Dec. 2025 was €0 Mil.

Azelis Group NV  (HAM:2R7) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Azelis Group NV Research & Development Related Terms

Azelis Group NV Research & Development Historical Data

* Premium members only.

The historical data trend for Azelis Group NV's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Azelis Group NV Research & Development Chart

Azelis Group NV Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Research & Development
Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00

Azelis Group NV Semi-Annual Data
Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
HAM:2R7
52GF Score
Azelis Group NV HAM:2R7
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Azelis Group NV Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was €0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of €0 Mil mean?
Azelis Group NV (HAM:2R7) has a Research & Development of €0 Mil as of Dec. 2025. Research and development expense is the total cost for research and development activities. View historical data on Azelis Group NV and its competitors.
Is Azelis Group NV's Research & Development too high?
Azelis Group NV's current Research & Development is €0 Mil. Overall, Azelis Group NV has a GF Score™ of 52/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Azelis Group NV's Research & Development compare to LIN and SHW?
Azelis Group NV's Research & Development of €0 Mil can be compared against companies in the Chemicals industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Chemicals company?
A good Research & Development depends on the Chemicals industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Azelis Group NV and its competitors. Azelis Group NV's current Research & Development is €0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Azelis Group NV stock overvalued right now?
Based on GuruFocus' analysis, Azelis Group NV (HAM:2R7) is currently considered Significantly Undervalued. The stock's GF Value™ is €18.35, compared to a current price of €9.69 — trading 47.2% below its estimated fair value. The current Research & Development is €0 Mil. Azelis Group NV's overall GF Score™ is 52/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Azelis Group NV (HAM:2R7), the current Research & Development is €0 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Azelis Group NV (HAM:2R7) Overvalued in 2026?

Based on GuruFocus' analysis, Azelis Group NV stock appears to be undervalued. The current stock price of €9.69 is trading 47.2% below its estimated GF Value™ of €18.35. GuruFocus considers Azelis Group NV to be Significantly Undervalued.

Key valuation signals for HAM:2R7:

  • Research & Development: €0 Mil
  • GF Value™: €18.35 vs. price of €9.69 (47.2% below fair value)
  • GF Score™: 52/100 with 4 warning signs

No single metric tells the full story. See the HAM:2R7 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Azelis Group NV Business Description

Address Posthofbrug 12, Box 6, Berchem, Antwerp, BEL, 2600
Azelis Group NV is an innovation service provider and distributor of speciality chemicals and food ingredients. The Group provides innovation services, multi-product formulations, technical and regulatory expertise, co-creation support, digital solutions, and supply chain services. It serves Food & Nutrition, Animal Nutrition, Personal Care, Home Care & Industrial Cleaning, Pharmaceuticals & Healthcare, Agriculture & Environmental Solutions, Flavours & Fragrances, and Nutraceuticals. The Group operates through four segments: EMEA, Americas, Asia Pacific, and Group holding & other, covering operating companies across Europe, the Middle East and Africa, the United States, Canada, Mexico and South America, Asia, and the Pacific region.
52GF Score

Get the complete analysis for HAM:2R7

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€9.69
Price
€18.35
GF Value